Effects of fluoxetine on hippocampal rhythmic slow activity and behavioural inhibition

被引:15
作者
Munn, Robert G. K. [1 ]
McNaughton, Neil [1 ]
机构
[1] Univ Otago, Dept Psychol, Dunedin, New Zealand
来源
BEHAVIOURAL PHARMACOLOGY | 2008年 / 19卷 / 03期
基金
英国医学研究理事会; 英国惠康基金;
关键词
anxiety; behavioural inhibition; differential reinforcement of low rates; fixed interval; fluoxetine; hippocampus; rat; rhythmic slow activity; theta;
D O I
10.1097/FBP.0b013e3282ff1300
中图分类号
B84 [心理学]; C [社会科学总论]; Q98 [人类学];
学科分类号
03 ; 0303 ; 030303 ; 04 ; 0402 ;
摘要
Anxiolytics that act as GABA(A) agonists and those that act as 5-HT1(1A) receptor agonists all reduce the frequency of hippocampal rhythmic slow activity (RSA Changes in RSA have been linked to changes in behavioural inhibition and therefore anxiety - but this has not been tested with specific serotonin reuptake inhibitors, which are antidepressant and anxiolytic; therefore we tested the effects of fluoxetine on RSA and behavioural inhibition. Fluoxetine (FLU; 10 and 20 mg/kg, intraperitoneally) produced a dose-related reduction in the frequency of reticular-elicited RSA. Groups of rats received, intraperitoneally, either (i) saline, or 5 mg/kg fluoxetine, or 10 mg/kg fluoxetine; or (ii) saline, or 20 mg/kg fluoxetine, or 6.6 mg/kg of the 5-HT1A agonist buspirone (BUS) and were tested on a fixed interval 60-s schedule and a differential reinforcement of low rates 15-s schedule. FLU at 5 mg/kg produced effects similar to low doses of BUS and other anxiolytics. FLU (110 and 20 mg/kg) produced effects more like those reported earlier for higher doses of BUS. These results continue to link anxiolysis, RSA and behavioural inhibition, and suggest that serotonergic anxiolytics share some of the central actions of GABAergic anxiolytics, but at higher doses, administered acutely, have distinct side effects that can obscure their anxiolytic action in behavioural tasks.
引用
收藏
页码:257 / 264
页数:8
相关论文
共 36 条
[1]  
[Anonymous], 2000, NEUROPSYCHOLOGY ANXI
[2]   Selective serotonin reuptake inhibitor treatment for generalized anxiety disorder: A double-blind, prospective comparison between paroxetine and sertraline [J].
Ball, SG ;
Kuhn, A ;
Wall, D ;
Shekhar, A ;
Goddard, AW .
JOURNAL OF CLINICAL PSYCHIATRY, 2005, 66 (01) :94-99
[3]   Direct action of serotonin on prolactin, growth hormone, corticotropin and luteinizing hormone release in cocultures of anterior and posterior pituitary lobes:: Autocrine and/or paracrine action of vasoactive intestinal peptide [J].
Balsa, JA ;
Sánchez-Franco, F ;
Pazos, F ;
Lara, JI ;
Lorenzo, MJ ;
Maldonado, G ;
Cacicedo, L .
NEUROENDOCRINOLOGY, 1998, 68 (05) :326-333
[4]  
BALSTER RL, 1982, J CLIN PSYCHIAT, V43, P34
[5]   The serotonin-1A receptor antagonist WAY-100635 modifies fluoxetine's antidepressant-like profile on the differential reinforcement of low rates 72-s schedule in rats [J].
Cousins, MS ;
Seiden, LS .
PSYCHOPHARMACOLOGY, 2000, 148 (04) :438-442
[6]  
Davidson JRT, 2001, J CLIN PSYCHIAT, V62, P46
[7]   EFFECTS OF BUSPIRONE AND CHLORDIAZEPOXIDE ON PLASMA-CATECHOLAMINE AND CORTICOSTERONE LEVELS IN STRESSED AND NONSTRESSED RATS [J].
DEBOER, SF ;
SLANGEN, JL ;
VANDERGUGTEN, J .
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 1991, 38 (02) :299-308
[8]   BUSPIRONE - REVIEW OF ITS PHARMACOLOGY AND CURRENT PERSPECTIVES ON ITS MECHANISM OF ACTION [J].
EISON, AS ;
TEMPLE, DL .
AMERICAN JOURNAL OF MEDICINE, 1986, 80 (3B) :1-9
[9]   SEROTONIN RECEPTOR SUBTYPES INVOLVED IN THE ELEVATION OF SERUM CORTICOSTERONE CONCENTRATION IN RATS BY DIRECT-ACTING AND INDIRECT-ACTING SEROTONIN AGONISTS [J].
FULLER, RW ;
SNODDY, HD .
NEUROENDOCRINOLOGY, 1990, 52 (02) :206-211
[10]  
FULLER RW, 1992, FRONT NEUROENDOCRIN, V13, P250